Literature DB >> 2679077

Mucormycosis: association with deferoxamine therapy.

A L Daly1, L A Velazquez, S F Bradley, C A Kauffman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2679077     DOI： 10.1016/s0002-9343(89)80836-8

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  18 in total

1.  The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.

Authors:  Brad Spellberg; Ashraf S Ibrahim; Peter V Chin-Hong; Dimitrios P Kontoyiannis; Michele I Morris; John R Perfect; David Fredricks; Eric P Brass
Journal:  J Antimicrob Chemother       Date:  2011-09-20       Impact factor: 5.790

Review 2.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 3.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Invasive and Allergic Fungal Sinusitis.

Authors:  Preeti N. Malani; Carol A. Kauffman
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 6.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Pulmonary invasive mucormycosis in a patient with secondary iron overload following deferoxamine therapy.

Authors:  Hector M Reyes; Eric J Tingle; Andrew Z Fenves; Jennifer Spiegel; Elizabeth C Burton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

Review 8.  Diseases and drug-related interventions affecting host defence.

Authors:  S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

Review 9.  Changing epidemiology of rare mould infections: implications for therapy.

Authors:  Anurag N Malani; Carol A Kauffman
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Hard palate perforation in acute lymphoblastic leukemia due to mucormycosis - a case report.

Authors:  Dipti R Samanta; Surendra N Senapati; Praveen K Sharma; B S Shruthi; Prajna Bimoch Paty; Gitanjali Sarangi
Journal:  Indian J Hematol Blood Transfus       Date:  2009-04-06       Impact factor: 0.900
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.